Anti-Cancer Drugs (journal)
Anti-Cancer Drugs (print: ISSN 0959-4973, online: ISSN 1473-5741) is an international medical journal, which aims to promote and encourage research on anti-cancer agents. It was first published in 1990 and it includes reports on clinical and experimental research results, from conventional cytotoxic chemotherapy to hormonal or biological response modalities. The journal has 10 issues per year and the current editor in chief is Mels Sluyser. According to the 2012 Journal Citation Reports, the journal has an impact factor of 2.232, ranking it 115th out of 197 in the category Oncology and 127th out of 261 in the category Pharmacology & Pharmacy.